Background: Infection with multiple cytomegalovirus (CMV) strains (mixed infection) was reported in a variety of hosts. As the virus genetic diversity in primary CMV infection and the changes over time remain incompletely defined, we examined CMV diversity and changes in diversity over time in healthy adolescent females who participated in a phase 2 CMV gB/MF59 vaccine trial.
Methods: CMV genetic diversity was determined by genotyping of 5 genes-gB (UL55), gH (UL75), gN (UL73), US28, and UL144-in urine, saliva, and plasma samples from 15 study subjects.
Results: At the time of primary infection, 5 of 12 (42%) urine samples had multiple virus strains, and 50% of vaccine recipients were infected with gB1 genotype (vaccine strain). Mixed infection was documented in all 15 subjects within 3 months after primary infection, and the majority had different CMV genotypes in different compartments. Changes in genotypes over time were observed in all subjects.
Conclusions: Infection with multiple CMV genotypes was common during primary infection and further diversification occurred over time. Infection with gB1 genotype in vaccine recipients suggests a lack of strain-specific protection from the vaccine. As only 5 polymorphic genes were assessed, this study likely underestimated the true genetic diversity in primary CMV infection.
Keywords: cytomegalovirus; diversity; primary infection; strains.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: firstname.lastname@example.org.
Genotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infection.Pediatr Infect Dis J. 2013 Oct;32(10):1050-4. doi: 10.1097/INF.0b013e31829bb0b9. Pediatr Infect Dis J. 2013. PMID: 23694837 Free PMC article.
Direct genotyping of cytomegalovirus envelope glycoproteins from toddler's saliva samples.J Clin Virol. 2009 Dec;46 Suppl 4:S43-8. doi: 10.1016/j.jcv.2009.08.018. Epub 2009 Oct 4. J Clin Virol. 2009. PMID: 19805004
Human cytomegalovirus UL55, UL144, and US28 genotype distribution in infants infected congenitally or postnatally.J Med Virol. 2015 Oct;87(10):1737-48. doi: 10.1002/jmv.24222. Epub 2015 Apr 29. J Med Virol. 2015. PMID: 25926093
Development of a cytomegalovirus vaccine: lessons from recent clinical trials.Expert Opin Biol Ther. 2001 May;1(3):401-12. doi: 10.1517/14712518.104.22.1681. Expert Opin Biol Ther. 2001. PMID: 11727514 Review.
Cytomegalovirus vaccine: phase II clinical trial results.Clin Microbiol Infect. 2014 May;20 Suppl 5(Suppl 5):95-102. doi: 10.1111/1469-0691.12449. Epub 2014 Jan 22. Clin Microbiol Infect. 2014. PMID: 24283990 Free PMC article. Review.